Cargando…
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections
BACKGROUND: In critically ill patients, the use of high tigecycline dosages (HD TGC) (200 mg/day) has been recently increasing but few pharmacokinetic/pharmacodynamic (PK/PD) data are available. We designed a prospective observational study to describe the pharmacokinetic/pharmacodynamic (PK/PD) pro...
Autores principales: | De Pascale, Gennaro, Lisi, Lucia, Ciotti, Gabriella Maria Pia, Vallecoccia, Maria Sole, Cutuli, Salvatore Lucio, Cascarano, Laura, Gelormini, Camilla, Bello, Giuseppe, Montini, Luca, Carelli, Simone, Di Gravio, Valentina, Tumbarello, Mario, Sanguinetti, Maurizio, Navarra, Pierluigi, Antonelli, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357259/ https://www.ncbi.nlm.nih.gov/pubmed/32661791 http://dx.doi.org/10.1186/s13613-020-00715-2 |
Ejemplares similares
-
Tigecycline pharmacokinetics in critically ill patients on renal replacement therapy: possible warnings and potential perspectives for the research agenda
por: Cutuli, Salvatore Lucio, et al.
Publicado: (2020) -
CO(2) driven endotracheal tube cuff control in critically ill patients: A randomized controlled study
por: De Pascale, Gennaro, et al.
Publicado: (2017) -
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features
por: De Pascale, Gennaro, et al.
Publicado: (2023) -
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria
por: De Pascale, Gennaro, et al.
Publicado: (2014) -
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case–control study
por: De Pascale, Gennaro, et al.
Publicado: (2017)